Metabolic regulation of pluripotency and germ cell fate through α-ketoglutarate. by Tischler, Julia et al.
Article
Metabolic regulation of pluripotency and germ cell
fate through a-ketoglutarate
Julia Tischler1 , Wolfram H Gruhn1,†, John Reid2,3,†, Edward Allgeyer1 , Florian Buettner4 ,
Carsten Marr4, Fabian Theis4,5 , Ben D Simons1, Lorenz Wernisch2 & M Azim Surani1,*
Abstract
An intricate link is becoming apparent between metabolism and
cellular identities. Here, we explore the basis for such a link in an
in vitro model for early mouse embryonic development: from naïve
pluripotency to the specification of primordial germ cells (PGCs).
Using single-cell RNA-seq with statistical modelling and modula-
tion of energy metabolism, we demonstrate a functional role for
oxidative mitochondrial metabolism in naïve pluripotency. We link
mitochondrial tricarboxylic acid cycle activity to IDH2-mediated
production of alpha-ketoglutarate and through it, the activity of
key epigenetic regulators. Accordingly, this metabolite has a role in
the maintenance of naïve pluripotency as well as in PGC differenti-
ation, likely through preserving a particular histone methylation
status underlying the transient state of developmental compe-
tence for the PGC fate. We reveal a link between energy metabo-
lism and epigenetic control of cell state transitions during a
developmental trajectory towards germ cell specification, and
establish a paradigm for stabilizing fleeting cellular states through
metabolic modulation.
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Introduction
Embryonic stem cells (ESCs) have the capacity for indefinite self-
renewal in vitro, while retaining the ability to differentiate into
specialized cell types (Ng & Surani, 2011; Young, 2011). The in vitro
differentiation of mouse ESCs (mESCs) from a naı¨ve pluripotent
state into primed epiblast-like cells (EpiLCs) confers transient devel-
opmental competence for the primordial germ cell (PGC) fate
(Hayashi et al, 2011) and provides a tractable model system for
investigations on early embryonic cell state conversions (Fig 1A).
These cell states and their transitions are associated with functional
heterogeneity, which needs consideration (Cahan & Daley, 2013).
While PGCs, the precursors of oocytes and sperm, and naı¨ve ESCs
share expression of some key pluripotency transcription factors,
together with DNA and histone methylation status, these are distinct
cell states (Saitou et al, 2003; Seki et al, 2005; Surani et al, 2007;
Hackett & Surani, 2013; Kurimoto et al, 2015).
Nutritional state, metabolism and the accompanying epigenetic
changes have an impact on cellular identity. For example, threonine
metabolism is linked to the synthesis of the methyl donor S-adenosyl-
methionine (SAM), which impacts on the histone methylation status,
and, in turn, mESC pluripotency (Shyh-Chang et al, 2013). Likewise,
the metabolite alpha-ketoglutarate (aKG) has a role in mESC self-
renewal through enhancing the efficiency of aKG-dependent dioxyge-
nases with key functions in the regulation of epigenetic state (Carey
et al, 2015), but also in the differentiation of human ESCs (hESCs;
TeSlaa et al, 2016). Similarly, aerobic glycolysis has been linked to
chromatin structure and the maintenance of hESC pluripotency, with
glycolysis-derived cytosolic acetyl-CoA serving as an essential
substrate for histone acetylation (Moussaieff et al, 2015). While
primed hESCs depend primarily on aerobic glycolysis, as is the case for
the mouse epiblast stem cells (EpiSCs), naı¨ve hESCs and mESCs utilize
both glycolysis and oxidative phosphorylation pathways on demand
(Zhou et al, 2012; Sperber et al, 2015). Consistently with their
predominantly glycolytic metabolism, stimulating aerobic glycolysis
via stabilization of hypoxia-inducible factor 1 alpha (HIF-1a) is suffi-
cient to drive mESCs into epiblast-like cell fates (Zhou et al, 2012).
Accordingly, activation of oxidative metabolism facilitates the re-acqui-
sition of naı¨ve pluripotency from highly glycolytic EpiSCs (Sone et al,
2017), suggesting that changes in cellular metabolism influence cell
state transitions. The precise molecular regulation underlying the
impact of energy metabolism on mESC pluripotency and during early
embryonic development, however, remains poorly defined.
Here, we identify metabolic regulatory pathways that are dynam-
ically modulated during the conversion from naı¨ve to primed
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pluripotency in mouse, and establish the influence of oxidative
metabolism on mESC pluripotency and developmental competence
for the PGC fate. We link oxidative mitochondrial metabolism and
tricarboxylic acid cycle to the production of aKG and, in turn, the
activity of key epigenetic regulators. On the basis of our findings,
we propose a metabolic regulatory mechanism via aKG, which
mediates early embryonic cell state transitions and germ cell devel-
opment through promoting permissive epigenetic states.
Results
Single-cell analysis reveals metabolic regulatory dynamics and
competence for the PGC fate
First, we used the in vitro differentiation of naı¨ve mouse embryonic
stem cells (ESCs) from pluripotent ground state (2i/Lif culture condi-
tions; Ying et al, 2008) into primed epiblast-like cell (EpiLC)
fates (Hayashi et al, 2011; Fig 1A), and performed single-cell
RNA-sequencing (RNA-seq) at t = 0, t = 24 and t = 48 h (Fig EV1A
and B). Gaussian process latent variable models (GPLVMs), a non-
linear dimensionality reduction approach (Lawrence, 2004; Buettner
& Theis, 2012), grouped individual cells into distinct transcriptional
states, which were highly correlated with sampling time (Fig EV1C).
We harnessed the cellular heterogeneity arising during EpiLC dif-
ferentiation to derive dynamic gene expression trajectories by statisti-
cally ordering single-cell transcriptomes over a developmental time
(“pseudotime”; Trapnell et al, 2014; Reid & Wernisch, 2016; Figs 1B
and EV1D), and comprehensively quantified expression level changes
(Appendix Table S1). Key regulators of naı¨ve pluripotency, such as
Esrrb and Tfcp2l1, displayed pronounced downward pseudotime pro-
files, while genes associated with epiblast development, such as Fgf5
and Lin28b, showed increasing expression over time; this recapitu-
lates the known expression dynamics (Hayashi et al, 2011). Central
regulators of energy metabolism exhibited similarly dynamic trajecto-
ries. Accordingly, pyruvate-dependent kinases 1 and 3 (Pdk1 and
Pdk3) and Slc2a1 and Stk11 (Fig EV1D) were upregulated over time,
conceivably contributing to enhanced glycolysis by suppressing entry
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Figure 1. Embryonic cell state transitions underlie dynamic changes in energy metabolism.
A Model depicting the conversion of mouse embryonic stem cells (ESCs) from a naïve pluripotent state in 2i/Lif culture conditions to primed epiblast-like cells (EpiLCs),
which acquire transient competence for induction into primordial germ cell (PGC)-like cell fate. Corresponding developmental stages are shown in the mouse embryo.
B Single-cell expression data in pseudotime of central regulators of naïve pluripotency, epiblast marker genes, glycolytic regulators and genes with key functions in
oxidative metabolism.
C Schematic illustrating the dynamic changes in energy metabolism during the acquisition of developmental competence for the PGC fate. TCA, tricarboxylic acid cycle.
Data information: See also Fig EV1.
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of pyruvate into the mitochondrial tricarboxylic acid (TCA) cycle and
by facilitating glucose uptake, respectively. Conversely, genes with
central roles in oxidative metabolism, such as Cox7a1 and Cpt1a,
exhibited a prominent decline. These dynamic expression changes
suggest a switch to an increased glycolytic state with a concomitant
decrease in oxidative metabolism (Fig 1C), as cells acquire compe-
tence for the PGC fate (Zhou et al, 2012; Zhang et al, 2016).
Oxidative mitochondrial metabolism maintains an embryonic
stem cell-like state
Next, we investigated potential implications of sustained oxidative
mitochondrial metabolism through repression of glycolysis for naı¨ve
pluripotency (Fig 2A). Using a knock-in reporter ESC line expressing
a destabilized green fluorescent protein from the endogenous
Zfp42/Rex1 locus (Rex1-GFPd2; Wray et al, 2011; Kalkan et al,
2017), we found that inhibition of glycolysis through supplementa-
tion of the glucose analogue 2-deoxy-D-glucose (2-DG; Wick et al,
1957; Zhou et al, 2012) prevented the exit from naı¨ve pluripotency,
indicated by the sustained expression of Rex1-GFPd2, in a dose-
dependent manner (Figs 2B and EV2A–C). Expression levels of
marker genes for naı¨ve pluripotency, including Esrrb, Klf4 and
Tfcp2l1, that were strongly downregulated in controls by t = 48 h
during the ESC-to-EpiLC transition remained elevated following
2-DG treatment (Fig 2C). Conversely, epiblast markers, such as
the de novo methyltransferase Dnmt3b, Fgf5 and Lin28b, were
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Figure 2. Oxidative metabolism promotes naïve pluripotency.
A Investigating the effect of sustained oxidative mitochondrial metabolism on the transition from naïve ESCs to primed EpiLCs through supplementation of the
glycolysis inhibitors 2-deoxy-D-glucose (2-DG) and dichloroacetate (DCA), respectively.
B Flow cytometry analysis of Rex1-GFPd2 cells following addition of 10 mM 2-DG during the 48 h EpiLC induction. Representative GFP intensity distributions are
depicted. Average proportions of Rex1-GFPd2-positive (GFP+) cells are quantified from two independent biological replicates. Error bars represent  SE. ***P = 0.0006
(unpaired 1-tailed Student’s t-test).
C Expression analysis by qRT–PCR of naïve pluripotency and epiblast marker genes in bulk 48 h cells after 10 mM 2-DG treatment. Relative expression levels,
normalized to control culture conditions, are shown. Graphs represent averages from triplicate (duplicate for Klf4 and Tfcp2l1) independent biological experiments.
Error bars denote  SE. *P ≤ 0.05; **P ≤ 0.01 (unpaired 1-tailed Student’s t-test, see Appendix Table S3 for exact P-values).
D Colony-forming ability following 10 mM 2-DG supplementation during EpiLC stimulation. Representative images of alkaline phosphatase (AP)-stained colonies are
displayed. Scale bar, 250 lm. The average colony formation, normalized to control culture conditions, quantified from two independent biological replicates, is
shown. Error bars signify  SE. *P = 0.0424 (unpaired 1-tailed Student’s t-test).
Data information: See also Fig EV2.
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repressed (Fig 2C). Further, glycolytic suppression also had an
impact on colony-forming ability, a hallmark of naı¨ve pluripotency.
While ESCs have the potential to self-renew and can generate colo-
nies from single cells in naı¨ve pluripotency-promoting conditions,
this ability is lost in 48 h EpiLCs (Murakami et al, 2016). The addi-
tion of 2-DG during the ESC-to-EpiLC differentiation, however,
resulted in the subsequent robust self-renewal and colony formation
(Fig 2D), supporting the maintenance of a naı¨ve pluripotent state.
Comparable results were obtained following treatment with the PDK
inhibitor dichloroacetate (DCA), which enhances the conversion
of pyruvate to acetyl-CoA in the mitochondria (Stacpoole, 1989;
Whitehouse et al, 1974; Fig EV2D–G).
Collectively, activation of mitochondrial oxidative metabolism
through inhibition of glycolysis sustains an ESC-like state, suggesting
that the oxidative-to-glycolytic switch might functionally promote
the conversion from naı¨ve to primed pluripotency and consequently
the acquisition of developmental competence for the PGC fate.
The TCA cycle metabolite aKG mediates the naïve pluripotency-
promoting effect of oxidative mitochondrial metabolism
Pseudotime expression profiles and quantitative analysis of
enzymes central to the mitochondrial TCA cycle revealed
pronounced downregulation of the aKG-producing enzyme Idh2 but
slight upregulation of the aKG-to-succinate-converting enzyme Dlst
(Fig 3A, Appendix Table S1), suggesting that aKG levels are dimin-
ished during the transition from naı¨ve to primed pluripotency.
Correspondingly, IDH2 protein levels were distinctly lower in 48
and 72 h EpiLCs, as compared to naı¨ve ESCs (Fig EV3A).
To investigate a potential functional link between oxidative mito-
chondrial metabolism, TCA cycle activity, and aKG levels, we exam-
ined the effect of sustained aKG supplementation on the ESC-to-
EpiLC transition. Addition of dimethyl-aKG (dm-aKG) during the
48 h EpiLC induction resulted in the retention of Rex1-GFPd2-posi-
tive cells in a dose-dependent manner (Figs 3B, and EV3B and C).
Indeed, cells cultured in 4 mM dm-aKG (Carey et al, 2015) retained
a homogeneous Rex1-high state, with a GFP intensity distribution
resembling naı¨ve ESCs (Fig 3B). As in naı¨ve ESCs, IDH2 levels were
high following dm-aKG supplementation during the EpiLC stimula-
tion, which is consistent with an active TCA cycle (Fig EV3A and
D). Accordingly, dm-aKG treatment during the EpiLC differentiation
promoted expression of the naı¨ve pluripotency regulators Esrrb, Klf4
and Tfcp2l1, while Dnmt3b, Fgf5 and Lin28b, marker genes of
epiblast, remained low (Figs 3C and EV3E). Moreover, the colony-
forming ability was strongly enhanced following EpiLC stimulation
in the presence of dm-aKG (Figs 3D and EV3F). The functional
similarity of cells subsequently to dm-aKG supplementation during
the 48 h EpiLC induction to naı¨ve ESCs was also reflected in the
mitochondrial morphology. Super-resolution imaging of immune-
stained outer mitochondrial membrane protein TOM-20 (Huang
et al, 2016) showed that, in the presence of dm-aKG, mitochondria
maintained a naı¨ve ESC-like oval morphology and did not form
elongated shapes, as observed in control EpiLCs (Figs 3E and
EV3G).
The effect of dm-aKG was reversible and did not compromise
ESC pluripotency and differentiation potential (Fig EV3H). Dm-aKG
pre-treatment of naı¨ve ESCs in 2i/Lif culture conditions, however,
led to the dose-dependent retention of cells in a Rex1-GFPd2-positive
state during transition to EpiLCs (Fig EV3I), proposing that the
intracellular aKG levels might need to diminish for an exit from
naı¨ve pluripotent state.
Together, our molecular, functional and morphological charac-
terizations suggest that aKG sustains an ESC-like state during EpiLC
induction.
The naïve pluripotency-promoting effect is specific to the TCA
cycle metabolite aKG
We then asked whether TCA cycle metabolites other than aKG
might support a naı¨ve pluripotent state. Supplementation of citrate,
▸Figure 3. aKG maintains naïve pluripotency.A Pseudotime expression profiles for the aKG-regulating enzymes Idh2 and Dlst during the transition from naïve to primed pluripotency. TCA cycle enzymes and
metabolites produced within the TCA cycle are illustrated.
B Representative flow cytometry profiles of Rex1-GFPd2 cells following 4 mM dm-aKG supplementation during the EpiLC induction are depicted. Graphs show
average fractions of Rex1-GFPd2-positive (GFP+) cells from six independent biological assays. Error bars indicate  SE. ***P = 1.241E-05 (unpaired 1-tailed
Student’s t-test).
C qRT–PCR analysis of naïve pluripotency regulators and epiblast marker genes following EpiLC stimulation in the presence of 4 mM dm-aKG. Expression data are
normalized to control culture conditions and represent averages from five biological replicates in bulk 48 h cells. Error bars denote  SE. ***P ≤ 0.005 (unpaired 1-
tailed Student’s t-test, see Appendix Table S3 for exact P-values).
D Colony-forming ability succeeding 4 mM dm-aKG treatment during the 48 h EpiLC induction. Characteristic images of AP-stained colonies are shown. Scale bar,
250 lm. Colony formation is normalized to control-treated cells and quantified from quadruplicate experiments. Error bars signify  SE. *P = 0.0283 (unpaired 1-
tailed Student’s t-test).
E Representative super-resolution images of TOM-20 immune-labelled mitochondria in ESCs following 48 h culture in 2i/Lif/KSR media, and EpiLC-inducing
conditions in the presence of 4 mM dm-aKG and DMSO, respectively, are displayed. Scale bar, 3 lm.
F–H Ten-day culture of Rex1-GFPd2 cells in N2B27/Lif/KSR with 4 mM dm-aKG and DMSO, respectively, with passaging every 2.5 days. (F) Characteristic bright-field
images of Rex1-GFPd2 cells after 10 days of culture in 2i/Lif/KSR and N2B27/Lif/KSR, in the presence of dm-aKG and DMSO, respectively. Scale bar, 10 lm. (G) Flow
cytometer-based quantification of Rex1-GFPd2-positive (GFP+) cells. Representative GFP intensity distributions are displayed. The average fractions of GFP+ cells
are measured from duplicate experiments. Error bars denote  SE. *P = 0.0477 (unpaired 1-tailed Student’s t-test). (H) qRT–PCR analysis of naïve pluripotency and
differentiation markers in bulk cells harvested at 2.5-day intervals during the 10-day culture in N2B27/Lif/KSR with dm-aKG or DMSO. Expression data are
normalized to time-matched ESCs in 2i/Lif/KSR culture conditions and are averaged over two independent biological experiments. Error bars indicate  SE.
*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005 (unpaired 1-tailed Student’s t-test, see Appendix Table S3 for precise P-values).
I Model illustrating the IDH2-mediated production of aKG in the mitochondrial TCA cycle during oxidative metabolism in ESCs in naïve pluripotency conditions.
Data information: See also Figs EV3 and EV4.
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a key metabolite upstream of aKG in the mitochondrial TCA cycle
(Fig 3A), during the EpiLC induction resulted in a moderate increase
in the fraction of Rex1-GFPd2-positive cells (Fig EV4A and B) and
colony-forming ability (Fig EV4C). Addition of the downstream
metabolite succinate, however, led to the loss of Rex1-GFPd2
expression and colony formation, comparable to control EpiLCs
(Fig EV4A–C). Together, these results suggest a highly specific func-
tion for aKG in the maintenance of an ESC-like state. We thus
propose that aKG relays the effect of enhanced oxidative metabo-
lism and TCA cycle activity on naı¨ve pluripotency.
A
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aKG promotes naïve pluripotency over multiple passages in the
absence of 2i inhibitors
Next, we explored whether aKG can replace 2i inhibitors in sustain-
ing naı¨ve pluripotency. Addition of dm-aKG to N2B27 media supple-
mented with Lif and KSR, which on its own rapidly induces
differentiation, supported round, dome-shaped colony morphology,
similar to naı¨ve ESCs, over at least 10 days and four passages,
respectively (Fig 3F). A minor fraction of cells differentiated in the
presence of dm-aKG, as judged by their elongated, flat shape, remi-
niscent of feeder cells forming a support layer. Flow cytometry anal-
ysis of Rex1-GFPd2 reporter cells confirmed observations from
visual inspection; following 10 days of culture with dm-aKG, a large
proportion of cells were Rex1-GFPd2-positive (Fig 3G). Transcript
levels of the ESC marker genes Esrrb and Tet2 remained elevated in
the presence of dm-aKG, further supporting maintenance of naı¨ve
pluripotency (Fig 3H). Together, these data suggest that aKG can, at
least partially, replace 2i inhibitors in the culture media to sustain
an ESC-like state over multiple passages.
aKG supports naïve pluripotency via cell cycle-dependent and
independent mechanisms
We then asked whether the effect of aKG was due to a decrease in
cellular proliferation (Fig EV4D). We thus assessed whether the naı¨ve
pluripotency-promoting effect specific to dm-aKG was conferred
through its direct impact on proliferation, or whether it was mediated
primarily via cell cycle-independent mechanisms. Slowing down
proliferation rates by treatment with a cyclin-dependent kinase 4
(CDK4) cell cycle inhibitor (CDK4i; Zhu et al, 2003; Roccio et al,
2013) during the ESC-to-EpiLC transition led to the dose-dependent
retention of cells in a Rex1-GFPd2-positive state (Fig EV4E), demon-
strating that slowing down of the cell cycle delayed exit from naı¨ve
pluripotency. However, at equivalent proliferation rates, the fraction
of Rex1-GFPd2-positive cells following dm-aKG supplementation
exceeded the fraction of Rex1-GFPd2-positive cells following CDK4
inhibition (Fig EV4F). Furthermore, at matching proliferation rates,
expression levels of marker genes for naı¨ve pluripotency were signifi-
cantly higher in dm-aKG-treated cells, as compared to CDK4-inhibited
cells (Fig EV4G). Thus, by revealing an enhanced effect of dm-aKG
treatment on naı¨ve pluripotency over merely reduced proliferation
rates, our data point to additional, cell cycle-independent effects
underlying the impact of aKG on pluripotent state.
aKG supports ESC pluripotency via maintenance of a naïve
epigenetic state
aKG is a known co-factor for a multitude of aKG-dependent
dioxygenases, many of which play central roles in the regulation
of chromatin structure, such as the histone H3 lysine 9 dimethyl
(H3K9me2) demethylases KDM3A and KDM3B, and the ten-
eleven translocation (TET) enzymes TET1 and TET2 (Klose et al,
2006; Kaelin, 2011; Losman & Kaelin, 2013). Consistently, combi-
natorial knockdown of the H3K9me2 demethylases Kdm3a and
Kdm3b resulted in the reduced colony formation following EpiLC
induction in the presence of dm-aKG (Fig EV4H and I). Accord-
ingly, differences in expression levels of selected ESC and
epiblast marker genes were minimized between dm-aKG- and
control-treated EpiLCs in Tet1/Tet2 double-knockout (DKO;
Dawlaty et al, 2013) cells (Fig EV4J). This suggests that aKG
supports naı¨ve pluripotency, at least in part, through increasing
the efficiency of KDM3A and KDM3B, and TET1 and TET2,
respectively.
aKG promotes germ cell fate
Expression of naı¨ve pluripotency genes in primordial germ cells
(PGCs), the precursors of sperm and eggs, indicates that they
have a role in a different context (Saitou et al, 2003). Remark-
ably, as in naı¨ve ESCs, the genes encoding for COX7A1, a central
regulator of mitochondrial oxidative metabolism, and the aKG-
producing enzyme IDH2 are upregulated in PGC-like cells
(PGCLCs) generated from EpiLCs via embryoid body formation in
the presence of cytokines (Hayashi et al, 2011; Fig EV5A). This
suggests that oxidative metabolism and aKG synthesis are
enhanced during PGC development. We also note increased
expression of Pdk1/3 in PGCLCs, which merits further investiga-
tion in the future. Thus, to examine the impact of aKG on PGC
fate, we induced PGCLCs from Prdm1-GFP (Ohinata et al, 2005)
EpiLCs. PGCLC stimulation under addition of dm-aKG led to a
roughly 50% increase in the proportion of Prdm1-GFP-positive
cells by day 4 (Figs 4A and EV5B), albeit with a slightly reduced
PGCLC embryoid size, likely due to aKG’s impact on cellular
proliferation. The key PGC regulators Prdm1, Prdm14, Tfap2c and
Brachyury (T) were highly expressed, while the ESC-specific gene
Klf4 was repressed in Prdm1-GFP-positive PGCLCs induced in the
presence of dm-aKG (Fig EV5C). Transcript levels of the endo-
derm-specific gene Gata6 were low, suggesting that dm-aKG was
specifically enhancing PGC fate. Moreover, robust expression of
the aKG-dependent methylcytosine dioxygenase 1, Tet1, and the
H3K9me2 demethylases Kdm3a and Kdm3b is noteworthy, as
these changes allow for the loss of DNA methylation in PGCs.
Collectively, our data suggest that dm-aKG supports specification
of Prdm1-GFP-positive PGCLCs.
Stimulation with BMP4 alone is sufficient to drive PGC devel-
opment within 2 days (Aramaki et al, 2013). We next explored
the impact of dm-aKG without BMP4/8 in inducing PGC fate.
Indeed, dm-aKG increased the proportion of Prdm1-GFP-positive
cells within 2–4 days by almost twofold over controls (Figs 4B,
and EV5D and F), with pronounced expression of Prdm1, Prdm14
and Tfap2c (Fig EV5E). These data indicate that dm-aKG alone is
sufficient to stimulate PGC development from EpiLCs, albeit with
reduced efficiency. This increase was partially reversed by treat-
ment with LDN-193189, a small molecule inhibitor of BMP type I
receptors (Loh et al, 2014; Fig EV5F), suggesting that aKG acts in
concert with endogenous BMP signalling to promote PGCLC dif-
ferentiation.
aKG safeguards the transient state of developmental
competence for the PGC fate
Next, we investigated the impact of aKG on the PGC specification
competency. Addition of dm-aKG from 24 to 48 h after the initiation
of EpiLC differentiation significantly reduced the number of Prdm1-
GFP-positive cells in day-4 PGCLC aggregates (Fig EV6A and B),
conceivably through retaining cells in an ESC-like state. Dm-aKG
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supplementation at 48 h, however, during the course of PGCLC
induction, resulted in a robust proportion of Prdm1-GFP-expressing
cells in day-4 PGCLC embryoids (Figs 4A and EV5B). Remarkably,
the addition of dm-aKG at 48 h during the EpiLC differentiation also
markedly prolonged the transient state of competence from its peak
at 48 h, up to 72 h (Figs 4C and EV6C). Thus, the induction effi-
ciency of Prdm1-GFP-positive PGCLCs from dm-aKG-treated 72 h
EpiLCs was comparable to those specified from control-treated
48 h EpiLCs. These cells showed appropriate expression of the key
germ cell regulators Prdm1, Prdm14, Tfap2c and Brachyury (T)
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(Fig 4D). Accordingly, Tet1, Kdm3a and Kdm3b were robustly
expressed, while the ESC-specific regulator Klf4 and the endoderm-
specific marker gene Gata6 were repressed (Fig 4D). Of note, in
the control EpiLCs, the competent state for the specification of
Prdm1-GFP-positive PGCLCs largely declines after 48 h (Figs 4C
and EV6C).
Acquisition of competence for the PGC fate is associated with
dynamic changes in activities of epigenetic regulators (Surani et al,
2007; Hayashi et al, 2011; Hackett & Surani, 2013; Kurimoto et al,
2015), which include those that are modulated by aKG (Klose
et al, 2006; Kaelin, 2011; Losman & Kaelin, 2013). Global
H3K9me2 levels rose and H3K27me3 levels declined during the
EpiLC differentiation (Fig EV3A), which recapitulates the known
histone methylation dynamics during early mouse development
(Kurimoto et al, 2015; Zylicz et al, 2015). Notably, dm-aKG treat-
ment preceding the acquisition of developmental competence for
the PGC fate prevented cells from attaining the high H3K9me2
and, conversely, low H3K27me3 levels detected in the control 48 h
EpiLCs (Fig 4E), in line with the characteristic epigenetic state of a
relatively naı¨ve cell state (Fig EV3A). Similarly, dm-aKG supple-
mentation beyond the time of acquisition of developmental compe-
tence broadly sustained H3K9me2 and H3K27me3 levels of PGC-
competent 48 h control EpiLCs (Fig 4E). Likewise, in dm-aKG-
treated EpiLCs, the levels of the de novo DNA methyltransferase,
DNMT3b, were maintained unlike in controls, which showed an
increase between 48 and 72 h (Fig 4E). These results suggest that
aKG stabilizes the transient developmental potential for the PGC
fate through preserving the particular epigenetic state of competent
EpiLCs.
Notably, locus-specific analysis of H3K9me2 and H3K27me3 by
ChIP-qPCR revealed that dm-aKG counteracts the accumulation of
H3K9me2, particularly on some enhancer elements associated with
the genes for the naı¨ve pluripotent state (Zylicz et al, 2015), such
as Esrrb, Nanog, Prdm14 and Arid5b (Figs 4F and EV6D). Consis-
tently, levels for the H3K27me3 mark were higher on these loci,
except for Prdm14, where we detected no change. However, on
loci, such as in the enhancer region of the PGC regulator Tfap2c,
both repressive marks are increased. This is in line with a general
repression of germline genes during epiblast development (Kuri-
moto et al, 2015). We reason that this locus-specific effect might
reflect the selective recruitment of aKG-dependent H3K9me2
demethylases, which is consistent with the subtle changes in
global H3K9me2 levels.
In summary, aKG enhances PGCLC differentiation potential via
synergistic action with BMP signalling and prolongs the time of
developmental competence for PGC specification, at least partially,
through maintaining H3K9me2, H3K27me3 and DNMT3b largely at
levels of PGC-competent 48 h EpiLCs. We also uncover a locus-
specific effect of dm-aKG; we find that low levels of H3K9me2 mark
a subset of cis-regulatory regions, in particular enhancers of pluripo-
tency-associated genes. In contrast, other regulatory regions, such
as enhancers of germ cell-associated genes, show an increase in
their H3K9me2 levels, irrespective of dm-aKG treatment. Through
safeguarding a permissive epigenetic state for the PGC fate, aKG
might recruit a larger proportion of cells into the competent state,
which, in turn, increases the number of Prdm1-GFP-positive
PGCLCs. Together, our findings extend the interrelation between an
oxidative metabolic state, the central TCA cycle metabolite aKG,
methylation status and naı¨ve pluripotency, to germ cell develop-
ment (Figs 4G and EV6E).
Discussion
Single-cell RNA-seq during the in vitro transition of naı¨ve mouse
embryonic stem cells (ESCs) into primordial germ cell (PGC)-
competent epiblast-like cells (EpiLCs) and quantitative data analy-
sis support a metabolic switch from an oxidative to an exceedingly
glycolytic state (Zhou et al, 2012; Zhang et al, 2016). Correspond-
ingly, we reveal dynamic upregulation of Lin28b, which plays a
crucial role in the suppression of genes involved in oxidative meta-
bolism and the regulation of mammalian glucose metabolism (Zhu
et al, 2011; Zhang et al, 2016). Pseudotime trajectories also reca-
pitulate other known metabolic regulatory dynamics, such as high
expression of threonine dehydrogenase (Tdh) in naı¨ve ESCs,
with a sharp decline during EpiLC differentiation (Fig EV1D,
◀ Figure 4. aKG promotes PGC fate.A FACS analysis of Prdm1-GFP-positive (GFP+) cells in day-4 embryoids specified in the presence of 4 mM dm-aKG and PGC cytokines. Representative flow cytometer
profiles are depicted. Graphs show the average fractions of GFP+ cells from duplicate experiments. Error bars denote  SE. *P = 0.0526 (unpaired 1-tailed Student’s
t-test). P1-GFP, Prdm1-GFP.
B FACS analysis of Prdm1-GFP-positive (GFP+) cells in day-2 embryoids aggregated under addition of LIF (10 ng ml1) and BMP4 (500 ng ml1), dm-aKG (4 mM) or
DMSO. Representative flow cytometer profiles are displayed. Average fractions of GFP+ cells are calculated from duplicate assays. Error bars denote  SE.
*P = 0.0526. P1-GFP, Prdm1-GFP.
C FACS analysis of Prdm1-GFP-positive (GFP+) cells in day-4 PGCLC aggregates specified from 4 mM dm-aKG-treated (t = 48 to t = 72 h) EpiLCs. Representative flow
cytometer profiles are depicted. The average fractions of GFP+ cells, quantified from triplicate experiments, are shown. Error bars signify  SE. *P ≤ 0.05; **P ≤ 0.01;
***P ≤ 0.005 (unpaired 1-tailed Student’s t-test, see Appendix Table S3 for precise P-values). P1-GFP, Prdm1-GFP.
D Transcript analysis by qRT–PCR of PGC specifiers, demethylating enzymes, mesoderm, endoderm and ESC regulators in FACS-sorted day-4 Prdm1-GFP embryoids
induced from 4 mM dm-aKG-treated 72 h EpiLCs. Expression levels are normalized to Prdm1-GFP-negative cells from control embryoids. Graphs represent averages
from triplicate experiments. Error bars indicate  SE. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005 (unpaired 1-tailed Student’s t-test, see Appendix Table S3 for precise P-
values). +, Prdm1-GFP-positive cells; , Prdm1-GFP-negative cells.
E Western blot analysis for H3K9me2, H3K27me3 and DNMT3b in 4 mM dm-aKG-treated EpiLCs. H3 is used as a loading control.
F ChIP-qPCR analysis of H3K9me2 and H3K27me3 in putative enhancer regions of genes associated with the naïve pluripotent state (Esrrb, Arid5b) and PGC fate
(Tfap2c), respectively, in naïve ESCs and at t = 48 h following EpiLC induction in the presence of 4 mM dm-aKG and DMSO, respectively. Graphs show enrichment of
H3K9me2, H3K27me3 and IgG control, respectively, relative to DMSO-treated EpiLCs. Averages represent triplicate independent experiments. Error bars signify  SE.
*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005 (unpaired 1-tailed Student’s t-test, see Appendix Table S3 for precise P-values).
G Model illustrating the extension of the transient developmental competence for the PGC fate through aKG.
Data information: See also Figs EV5 and EV6.
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Appendix Table S1), consistent with the requirement of threonine
metabolism for maintaining ESC pluripotency (Shyh-Chang et al,
2013). A shift to a predominantly glycolytic metabolism in the
post-implantation epiblast (Zhou et al, 2012; Zhang et al, 2016)
seems important for the competent state and PGC fate.
We propose a critical function for an active mitochondrial oxida-
tive metabolism in the replenishing of intracellular aKG levels,
which, in turn, promotes demethylating enzymes central to naı¨ve
pluripotency and PGC fate. Transcript and protein dynamics of the
TCA cycle enzyme IDH2 suggest that aKG levels accumulate in the
naı¨ve pluripotent state and decline during EpiLC differentiation
(Fig 3I). Consistently, recent studies measured intracellular aKG
concentrations to be lower in primed (serum/Lif-cultured) or dif-
ferentiated cells as compared to naı¨ve ESCs (Carey et al, 2015;
Hwang et al, 2016). However, in contrast to these reports, which
link regulation of intracellular aKG production to glycolysis-
coupling pathways (Hwang et al, 2016) and glutamine metabolism
(Carey et al, 2015), respectively, our results show negligible
changes in expression levels of enzymes implicated in the conver-
sion of aKG from glutamine and glutamate (Gls, Gls2, Glul, Glud1)
or the glycolysis-branched transaminases Psat1 and Psph, during the
ESC-to-EpiLC transition (Fig EV1D, Appendix Table S1). Instead, we
propose that enhanced mitochondrial oxidative metabolism and
TCA cycle stimulate aKG production from citrate through mitochon-
drial IDH2 in naı¨ve ESCs. Accordingly, our analysis reveals binding
of the key pluripotency factors OCT4, SOX2 and NANOG (OSN) in
the promoter region of Idh2 (Appendix Fig S1). No OSN binding by
our criterion is observed in the promoter regions of Dlst and Idh1,
encoding for cytosolic IDH, further supporting a link between mito-
chondrial oxidative metabolism, IDH2-mediated aKG synthesis and
naı¨ve pluripotency. Transition to a predominantly glycolytic meta-
bolism during EpiLC differentiation in turn limits IDH2-mediated
conversion of mitochondrial citrate to aKG, leading to a gradual
decrease in intracellular aKG levels. Correspondingly, we ascribe a
moderate pluripotency-promoting effect of citrate to IDH2-activity in
ESCs, likely resulting in aKG synthesis at the onset of EpiLC induc-
tion, before Idh2 is downregulated. Reduction or depletion of intra-
cellular aKG during EpiLC differentiation conceivably curbs the
activity of demethylating enzymes with key roles in preserving a
naı¨ve epigenetic state, such as the H3K9me2 demethylases KDM3A
and KDM3B (Ko et al, 2006; Loh et al, 2007) and the TET family
enzymes TET1 and TET2 (Costa et al, 2013; Hackett & Surani,
2014). Interaction with additional aKG-dependent dioxygenases
might further contribute to the naı¨ve pluripotency-promoting effect
of aKG.
Collectively, we propose that release from an oxidative meta-
bolic state and diminution of aKG levels are a pre-requisite for the
exit from naı¨ve pluripotency and its unique epigenetic state, and
successively the acquisition of developmental competence for the
germ cell fate. Importantly, we uncouple cell cycle-dependent from
cell cycle-independent effects of aKG. To our knowledge, this study
is the first to show that limiting cellular proliferation rates during
EpiLC induction sustains an ESC-like state. Critically, we demon-
strate that aKG can largely replace 2i inhibitors (Ying et al, 2008) in
maintaining a naı¨ve pluripotent state, suggesting that culture in 2i-
conditions may stimulate intracellular aKG production and accumu-
lation. Carey et al (2015) recently proposed metabolic re-wiring in
2i culture conditions as a potential mechanism for enabling
glutamine-independent growth of naı¨ve ESCs. However, the molec-
ular basis underlying the re-routing of metabolic flux to increase
intracellular aKG levels upon 2i culture remains to be explored. The
precise regulatory mechanisms linking 2i culture conditions to mito-
chondrial respiration merit further investigation into the potential
crosstalk between signalling pathways and metabolic state.
While mitochondrial oxidative metabolism declines during the
ESC-to-EpiLC transition, super-resolution imaging reveals that, as in
EpiSCs (Zhou et al, 2012), mitochondria are more elongated and
hence likely more developed in EpiLCs than in ESCs, most probably
to meet the metabolic requirements of enhanced oxidative metabo-
lism during later stages of development (Folmes et al, 2012).
Consistently, we find that PGCLCs express higher levels of Cox7a1
and Idh2 transcripts, suggesting a boost in mitochondrial oxidative
metabolism. Accordingly, activation of mitochondrial oxidative
metabolism by 2-DG supplementation results in enhanced PGCLC
induction (Hayashi et al, 2017). The molecular mechanisms under-
lying the promotion of PGC fate through stimulation of oxidative
metabolism, however, remain to be discovered. Here, we show
that aKG largely preserves the histone methylation state underlying
the developmental competence for the PGC fate, and extend the
interrelation between mitochondrial oxidative metabolism, aKG
and epigenetic control from the naı¨ve pluripotent state to PGC
development.
Notably, the cellular response to aKG changes during the devel-
opmental transition from naı¨ve pluripotency to PGC competency;
within the first 24 h of EpiLC differentiation, aKG retains cells in a
Rex1-high pluripotent state, with low competency for the PGC fate.
By contrast, addition of aKG once EpiLCs have acquired PGCLC
competency significantly extends the narrow time window of devel-
opmental competence for the PGC fate, without affecting the effi-
ciency of the PGCLC induction.
We propose an appropriate balance between H3K9me2 acquisi-
tion and H3K27me3 depletion as being a key to the developmental
competence for the PGC fate, which is sustained by dm-aKG. Of
note, dm-aKG supplementation at the time of competence does not
restore the very low H3K9me2 levels as found in naı¨ve ESCs.
Instead, through activating aKG-dependent H3K9me2 demethylases,
aKG opposes the differentiation-induced H3K9me2 accumulation on
certain loci and consequently prevents the genome-wide reduction
of H3K27me3 levels. Low levels of DNA demethylation induced by
aKG might further promote the spreading of H3K27me3 at high CpG
regions (Zylicz et al, 2015).
In summary, we suggest that aKG prolongs fleeting developmen-
tal states, such as naı¨ve pluripotency and the transient potential for
PGC fate, respectively, through safeguarding their particular epige-
netic states. It is conceivable that aKG also stabilizes transitory
cellular states in other contexts and might potentially provide a
universal tool for capturing and expanding short-lived cell states
in vitro through metabolic modulation.
Materials and Methods
Cell lines
C57BL/6 wild-type mouse embryonic stem cells (ESCs; clone C8
was used in this study; Grabole et al, 2013) were derived in 2i
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conditions as described previously (Nichols et al, 2009). For
Prdm1-GFP ESCs (clone BG5 was used in this study), morula-
stage embryos were harvested from uteri of female mice (129
strain) crossed with Prdm1-GFP transgene male mice (Ohinata
et al, 2005). Following 24 h culture in KSOM (Merck) and
removal of zona pellucida, blastocyst-stage embryos were
harvested on mouse embryonic fibroblasts and cultured in 2i/Lif
conditions in GMEM with 10% foetal calf serum (FCS; Gibco).
Rex1-GFPd2 ESCs were a gift from Tuzer Kalkan (Wray et al,
2011; Kalkan et al, 2017). Tet1/2 wild-type and double-knockout
(DKO) ESCs (wild-type clone 4 and DKO clone 51) were received
from Rudolf Jaenisch (Dawlaty et al, 2013). Bill Skarnes and Peri
Tate provided E14tg2a wild-type ESCs.
Cell culture and differentiation
Mouse ESCs were maintained in N2B27, supplemented with 1 lM
PD0325901 (Miltenyi Biotec), 3 lM CHIR99021 (Miltenyi Biotec)
and 10 ng ml1 LIF (Stem Cell Institute, University of Cambridge
(SCI); “2i/Lif” culture conditions; Ying et al, 2008) on 0.1% gela-
tine-coated Nunc cell culture dishes (Thermo Fisher Scientific). For
maintaining Prdm1-GFP ESCs, foetal calf serum (FCS; Gibco) was
added to a final concentration of 5% to 2i/Lif culture medium. Cells
were passaged every 2–3 days using TrypLE Express or Accutase
(for Rex1-GFPd2 ESCs), with media exchange on alternate days.
ESCs were grown for at least one passage on dishes coated with
16.67 lg ml1 human plasma fibronectin (FC010; Millipore) in 2i/
Lif with 1% knockout serum replacement (KSR, Thermo Fisher
Scientific; “2i/Lif/K”) before inducing epiblast-like cells (EpiLCs).
For differentiation experiments, approximately 25,000 cells per cm2
were plated in fibronectin-coated dishes in EpiLC-inducing culture
conditions (N2B27 supplemented with 20 ng ml1 activin A (SCI),
12 ng ml1 bFGF (SCI) and 1% KSR), with daily media change
(Hayashi et al, 2011; Hayashi & Saitou, 2013). Cells were harvested
at t = 48  5 h for downstream assays. For EpiLC differentiation
experiments exceeding t = 48  5 h, the initial plating density was
adjusted accordingly. For primordial germ cell-like cell (PGCLC)
specification, 48 h EpiLCs were aggregated as embryoid bodies in
Corning Costar ultra-low attachment 96-well plates (Sigma) at 2,000
cells in 100 ll droplets per well in GMEM BHK-21 (Gibco) with 15%
KSR, 0.1 mM NEAA (Thermo Fisher Scientific), 1 mM sodium-
pyruvate (Sigma), 2 mM L-glutamine (Sigma), 0.1 mM 2-mercap-
toethanol (Thermo Fisher Scientific), 100 U ml1 penicillin and
0.1 mg ml1 streptomycin (Sigma), supplemented with 500 ng ml1
BMP4 (R&D Systems), 500 ng ml1 BMP8a (R&D Systems),
100 ng ml1 SCF (R&D Systems), 50 ng ml1 EGF (R&D Systems)
and 10 ng ml1 LIF (SCF; Hayashi et al, 2011; Hayashi & Saitou,
2013).
Single-cell transcriptome profiling
For highly parallel processing of single cells from differentiation
time points t = 0 (ESCs 2i/Lif/K), t = 24 and t = 48 h, EpiLCs were
induced staggered from C57BL/6 wild-type ESCs (clone C8). Cells
were harvested by trypsinization and stained with 2 lg ml1
Hoechst 33342 (Invitrogen, 917368; ESCs 2i/Lif/K), 2.5 lg ml1
CellMask Deep Red plasma membrane stain (Molecular Probes, Life
Technologies, C10046; 24 h EpiLCs), and 4 lM ethidium
homodimer-1 and 2 lM calcein (LIVE/DEAD Viability/Cytotoxicity
Kit for mammalian cells, Molecular Probes, Life Technologies,
L3224; 48 h EpiLCs), respectively, for 20 min at 37°C in 5% CO2 in
1 ml N2B27 with 1% KSR (N2B27/K) each. Labelled cells were
washed twice in 500 ll N2B27/K, before combining cells from all
three time points in equal numbers for single-cell capture and simul-
taneous processing using the C1 Single-Cell AutoPrep System (C1
Integrated Fluidic Circuits for mRNA-seq (10–17 lm), Fluidigm,
100-5760; C1 Single-Cell AutoPrep Reagent Kit for mRNA-seq, Flui-
digm, 100-6201). Cell identities of single captured cells were decon-
voluted based on fluorescent dye labels, using an inverted Olympus
fluorescence microscope, before single-cell cDNAs were generated
on-chip by SMARTer technology (SMARTer Ultra Low RNA Kit for
Illumina Sequencing, Clontech, 634936; Advantage 2 PCR Kit, Clon-
tech, 639206; Ramskold et al, 2012). Multiplexed cDNA libraries of
single cells were prepared using the Nextera XT DNA Sample Prepa-
ration Kit (Illumina, FC-131-1096 and FC-131-1002) and sequenced
on the Illumina HiSeq 2000 platform. Extensive quality control anal-
ysis was performed, and only 67 single cells that met the following
criteria were included for further analysis:
(i) Cells that could be uniquely identified via fluorescence micro-
scopy and
(ii) Cells with equal or greater than 6 million uniquely mapping
reads.
Mapping of sequencing reads
Fastq files were filtered for low-quality reads (< Q20), and low-
quality bases were trimmed from read ends (< Q20) using the
FASTX-Toolkit. Adaptors were removed using CutAdapt (Martin,
2011). The resulting filtered files were mapped to the mouse
genome (UCSC mm9) using TopHat 2.0.6 (Trapnell et al, 2009; Kim
et al, 2013) with the UCSC mm9 junction file. BAM files generated
from multiple sequencing runs were merged with samtools 0.1.18
(Li et al, 2009). Transcript counts and RPKMs were calculated using
custom R scripts based on the GenomicRanges Bioconductor library
and annotation from the UCSC mm9 junction file. Scripts are avail-
able upon request.
FASTX-Toolkit: http://hannonlab.cshl.edu/fastx_toolkit/index.html
CutAdapt: http://journal.embnet.org/index.php/embnetjournal/arti
cle/view/200
TopHat: http://www.ncbi.nlm.nih.gov/pubmed/19289445
Samtools: https://www.ncbi.nlm.nih.gov/pubmed/19505943
Derivation of pseudotime trajectories
Single-cell transcript counts from time points t = 0, t = 24 and
t = 48 h during the ESC-to-EpiLC transition were combined, tran-
scripts with no variation removed, and data transformed by
log10(count + 1). Forty-eight hours EpiLCs with high Tfcp2l1 expres-
sion (log10(count + 1) > 1.5) were excluded. This left us with 56 out
of 67 cells. The R method DESeq2::estimateSizeFactorsForMatrix was
used for normalization. To fit the pseudotime model, genes encoding
for 135 transcripts, including central regulators of pluripotency,
genes associated with epiblast development, epigenetic regulators,
transcripts encoding for enzymes within key metabolic pathways and
those with the highest ratio of variance between capture time to
variance within capture time were chosen (Appendix Table S2). The
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DeLorean pseudotime method was applied, using the following
hyperparameters: rs = 8 h, l = 48 h. The DeLorean model was fit
with the No-U-Turn-Sample (NUTS). The null hypothesis (cells were
ordered no better than randomly) was rejected by The DeLorean
permutation roughness test with P < 1015.
Quantification of single-cell transcript level changes
For a comprehensive quantification of expression level changes of
478 transcripts encoding for metabolic regulators and control genes,
a representative pseudotime for the start and end, respectively, of
the ESC-to-EpiLC differentiation was estimated as the median pseu-
dotime for naı¨ve ESCs in 2i/Lif culture conditions and EpiLCs
captured at 48 h, respectively: a Gaussian process pseudotime
trajectory was fit to each transcript using the cells’ pseudotimes
inferred from fitting the DeLorean model (see “Derivation of pseu-
dotime trajectories” above). The Kullback–Leibler (KL) divergence
between the posterior distributions of the expression trajectory at
the representative naı¨ve ESCs and 48 h EpiLCs pseudotimes was
calculated as a quantitative measure of change in gene expression.
The KL divergence has several properties that make it suitable for
this purpose: it is invariant to shifting and scaling of the data;
however, it is sensitive to changes in the variance of the pseudotime
trajectory. Transcripts were ranked by their KL divergences
(Appendix Table S1); higher divergences indicate genes whose
distribution of expression has changed the most between the onset
and the end point of the ESC-to-EpiLC differentiation.
Metabolic modulation
For metabolic modulation, 1–10 mM 2-deoxy-D-glucose (2-DG,
Sigma-Aldrich, D6134) in dH2O, 5–20 mM sodium dichloroacetate
(DCA, Santa Cruz Biotechnology, Inc., sc-203275) in dH2O, 1–4 mM
dimethyl alpha-ketoglutarate (dm-aKG, Sigma-Aldrich, 349631),
4 mM sodium citrate dehydrate (Na-citrate, Sigma-Aldrich,
W302600) in dH2O and 4 mM dimethyl succinate (dm-succinate,
Sigma-Aldrich, W239607), respectively, were added to cell culture
media at the time of plating, with daily media change. For pharma-
cological modulation during PGCLC differentiation, 4 mM dm-aKG
and 500 nM small molecule inhibitor of bone morphogenetic protein
(BMP) type I receptors ALK2 and ALK3, LDN-193189 (“iBMP”,
Stemgent, 04-0074) in DMSO, respectively, were added once at the
time of embryoid body aggregation.
Colony formation assays
Following 48 h culture in EpiLC-inducing conditions in the presence
of metabolic modulators (2-DG, DCA, dm-aKG, Na-citrate, dm-succi-
nate), 2,000 cells were plated in fibronectin-coated 6-well plates in
2i/Lif medium with 3% FCS. The next day, cells were rinsed once
with 1×PBS and replenished with fresh culture medium. On day 6,
cells were fixed with 4% formaldehyde (Thermo Fisher Scientific,
PN28906) for 15 min at room temperature and stained for alkaline
phosphatase (AP) using Leukocyte Alkaline Phosphatase Kit
(Sigma-Aldrich, 86R) according to manufacturer’s instructions. AP-
positive colonies were quantified and imaged on an upright Zeiss
microscope (Stemi SV11), using Leica Application Suite software
(v4.1).
Quantifying cellular proliferation rates
To assess cellular proliferation, ESCs were stained with CellTrace
Violet Cell Proliferation Kit (Molecular Probes, Life Technologies,
C34557) following manufacturer’s instructions for labelling of
adherent cells, before EpiLC induction and subsequent quan-
tification of remaining dye levels by flow cytometry. For bench-
marking of proliferation rates, dye dilution in the presence of
increasing doses (0.1 lm–1 lM) of the cell-permeable cyclin-
dependent kinase 4 (CDK4) inhibitor 2-Bromo-12,13-dihydro-5H-
indolo[2,3-a]pyrrolocarbazole-5,7(6H)-dione (“CDK4i”, Calbiochem,
219476) in DMSO was compared to dye dilution following 4 mM
dm-aKG treatment. For gene expression analysis, cells were gated
based on CellTrace Violet intensities and collected by fluorescence-
activated cell sorting (FACS).
Flow cytometry
For flow cytometry, cells were re-suspended in 1×PBS with 3% FCS.
Flow cytometer analysis was performed on a BD FACScan; data
were analysed using BD CellQuest software. FACS sorting was
performed on a Moflo (for dye dilution experiments) and SONY
SH800 cell sorter (for PGCLC experiments). FACS data were evalu-
ated using FlowJo software.
Quantitative real-time PCR
RNA was extracted using the RNeasy Mini Kit (Qiagen, 74104; for
ESCs and EpiLCs) and Arcturus PicoPure RNA Isolation Kit (Applied
Biosystems, Thermo Fisher Scientific, 12204-01; for ESCs and
PGCLCs), with on-column DNase digestion (Qiagen, 79254). cDNAs
were generated using SuperScript III Reverse Transcriptase (Thermo
Fisher Scientific, 18080-044), according to manufacturer’s instruc-
tions. Quantitative real-time PCR was performed on a QuantStudio 6
Flex Real-Time PCR System (Applied Biosystems), with SYBR Green
JumpStart Taq ReadyMix (Sigma-Aldrich, S4438), in triplicate for
each condition. For each independent biological experiment, data
were averaged over technical triplicates and analysed using the
comparative Ct method (Schmittgen & Livak, 2008), with transcript
levels internally normalized to ActB expression levels. Primer pairs
used were as follows: ActB, forward, 50-CCCTAAGGCCAACCGTG
AAA-30, reverse, 50-AGCCTGGATGGCTACGTACA-30; Esrrb, forward,
50-GGCGTTCTTCAAGAGAACCA-30, reverse, 50-CTCCGTTTGGTGA
TCTCACA-30; Klf4, forward, 50-GGGGTCTGATACTGGATGGA-30,
reverse, 50-CCCCCAAGCTCACTGATTTA-30; Tfcp2l1, forward, 50-AG
GTGCTGACCTCCTGAAGA-30, reverse, 50-GTTTTGCTCCAGCTCC
TGAC-30; Dnmt3b, forward, 50-GACGTCCGGAAAATCACCAA-30,
reverse, 50-GATCATTGCATGGGCTTCCA-30; Fgf5, forward, 50-TA
CCCGGATGGCAAAGTCAA-30, reverse, 50-ATCCCCTGAGACACAGC
AAA-30; Lin28b, forward, 50-CGAGAGGGAAATCCCTTGGATA-30,
reverse, 50-CCACTGGCTCTCCTTCTTTCA-30; Prdm1, forward, 50-G
AGGATCTGACCCGAATCAA-30, reverse, 50-CTCAACACTCTCATGT
AAGAGGC-30; Prdm14, forward, 50-GCCTGAACAAGCACATGAG
A-30, reverse, 50-TGCACTTGAAGGGCTTCTCT-30; Tfap2c, forward,
50-CGCGGAAGAGTATGTTGTTG-30, reverse, 50-CGATCTTGATGG
AGAAGGTCA-30; Klf2, forward, 50-ACCAAGAGCTCGCACCTAAA-30,
reverse, 50-GTGGCACTGAAAGGGTCTGT-30; Nanog, forward, 50-AC
CTGAGCTATAAGCAGGTTAAGAC-30, reverse, 50-GTGCTGAGCCCT
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TCTGAATCAGAC-30; T, forward, 50-TCCCGAGACCCAGTTCATA
G-30, reverse, 50-TTCTTTGGCATCAAGGAAGG-30; Gata6, forward, 50-AA
CCCATTCATCCCCGACCAC-30, reverse, 50-CTCCTCTCCACGAACG
CTTGT-30; Sox7, forward, 50-AAACGTCTGGCAGTGCAGAAC-30,
reverse, 50-CAGCGCCTTCCATGACTTTCC-30; Tet1, forward, 50-AGA
TGGCTCCAGTTGCTTATCA-30, reverse, 50-ACGCCCCTCTTCATTT
CCAA-30; Kdm3a, forward, 50-ATTCGAGCTGTTTCCCACAC-30,
reverse, 50-TTTCTCCAAGACTCCCCATCA-30; Kdm3b, forward, 50-C
CATGACCCCAGCAACAAAA-30, reverse, 50-TGCACCCCTGAAACTA
GCA-30; Cox7a1, forward, 50-CGAAGAGGGGAGGTGACTC-30, reverse,
50-AGCCTGGGAGACCCGTAG-30; Cpt1a, forward, 50-GACTCCGCT
CGCTCATTC-30, reverse, 50-TCTGCCATCTTGAGTGGTGA-30; Idh2,
forward, 50-GGATGTACAACACCGACGAGT-30, reverse, 50-CGGCCA
TTTCTTCTGGATAG-30; Pdk1, forward, 50-GTTGAAACGTCCCG
TGCT-30, reverse, 50-GCGTGATATGGGCAATCC-30; Pdk3, forward,
50-AAGCAGATCGAGCGCTACTC-30, reverse, 50-TTCACATGCATTA
TCCCTTCC-30; Gapdh, forward, 50-CCCCAACACTGAGCATCTCC-30,
reverse, 50-ATTATGGGGGTCTGGGATGG-30.
Small-interfering RNA-mediated knockdown
For combinatorial knockdown via small-interfering RNAs (siRNAs),
275,000 ESCs cultured in 2i/Lif were reverse-transfected with
12.5 nM each of ON-TARGETplus Kdm3a siRNA (GE Healthcare
Lifesciences, L-056510-00-0005) and ON-TARGETplus Kdm3b
siRNA (GE Healthcare Lifesciences, L-065381-00-0005), and
25 nM ON-TARGETplus Non-targeting Pool (GE Healthcare Life-
sciences, D-001810-10-05) as control, respectively, using Dharma-
FECT 1 Transfection Reagent (Dharmacon, T-2001-02) according
to manufacturer’s instructions. For each condition, all cells were
plated in one 6-well plate coated with fibronectin in 2i/Lif/K
medium. The following day, cells were replenished with fresh 2i/
Lif/K medium and induced into EpiLCs 1 day later. Knockdown
efficiencies were derived by normalizing Kdm3a and Kdm3b,
respectively, expression levels in ESCs in 2i/Lif culture conditions
at t = 48 h after siRNA transfection to levels prior to siRNA trans-
fection (t = 0 h).
Mitochondria labelling
For staining mitochondria, cells grown on ethanol-cleaned, fibro-
nectin-coated microscope cover glasses (Marienfeld, 0107052) were
washed three times with 1×PBS warmed to 37°C, before 15-min fixa-
tion in 37°C pre-warmed 3% formaldehyde (Thermo Fisher Scien-
tific, PN28906) and 0.1% aqueous glutaraldehyde (Thermo Fisher
Scientific, 50-262-10) in 1×PBS at room temperature, followed by
three rinses in 1×PBS. Cells were permeabilized and blocked for 1 h
at room temperature in 3% BSA and 0.2% Triton X-100 in 1×PBS,
before incubating overnight with primary antibody (rabbit anti-
TOM20, FL-145, Santa Cruz Biotechnology, sc-11415) at a 1:1,000
dilution in 1% BSA and 0.2% Triton X-100 in 1×PBS in a humid
chamber at 4°C. Cells were rinsed three times in 0.05% Triton X-100
in 1×PBS and incubated with secondary antibody (anti-rabbit-IgG-
Atto 647N, Sigma-Aldrich, 40839) diluted 1:500 in 1% BSA and
0.2% Triton X-100 in 1×PBS for 1 h at room temperature in a humid
chamber protected from light. Following three washes in 0.05%
Triton X-100 in 1×PBS, antibody-stained cells were fixed for 10 min
in 3% formaldehyde (Thermo Fisher Scientific, PN28906) and 0.1%
aqueous glutaraldehyde (Thermo Fisher Scientific, 50-262-10) in
1×PBS at room temperature. Cell membranes were labelled with
5 lg ml1 wheat germ agglutinin, Alexa Fluor 488 conjugate (WGA-
488, Thermo Fisher Scientific, W11261) in 1×PBS for 10 min at room
temperature and rinsed three times in 1×PBS, before mounting onto
SuperFrost Plus microscope slides (VWR, 631-0108) in ProLong Gold
antifade reagent (Thermo Fisher Scientific, P36930). Slides were
sealed with nail varnish and stored at 4°C prior to imaging.
Imaging and analysis
Super-resolution imaging was performed on a custom-built STED
microscope featuring three excitation lines, one fixed depletion
wavelength, fast beam scanning and gated detection. The custom
STED microscope follows closely to the microscope described in
Bottanelli et al (2016) (hardware is identical, optical arrangement
differs slightly). All images were acquired with a 100× oil immersion
objective lens (Olympus, UPLSAPO 100XO/PSF). Either a
30 × 30 lm field of view with an image format of 2,048 × 2,048
(14 nm square pixel size) or a 10 × 10 lm field of view (“zoom-in”)
with a 1,024 × 1,024 image format (9.8 nm square pixel size) was
used. Unidirectional beam scanning was performed at 16 kHz with
synchronized beam blanking to reduce light exposure. Excitation
laser intensity was approximately 10–20 lW at the microscope side-
port and STED depletion power was 110–120 mW at the microscope
side-port. TOM-20 (Atto 647N) and membrane WGA (Alexa-488)
were imaged simultaneously although the STED depletion beam
only acts on the Atto 647N. Thus, one super-resolved STED mito-
chondria image and one confocal membrane image membrane were
acquired simultaneously. For each line of an image, each line was
scanned either 600 times (10 × 10 lm case) or 650 times
(30 × 30 lm case). For 10 × 10 lm images, acquisition time was
38 s. For the larger 30 × 30 lm images, acquisition time was 83 s.
To aid visualization, intensity scales (in units of counts) were
adjusted using Fiji software as follows:
ESC2 2i/Lif/K:
TOM-20 (mitochondria, magenta): 0–5 (30 × 30 lm). 0–9
(10 × 10 lm).
WGA-488 (membrane, green): 0–86 (30 × 30 lm).
48 h EpiLCs + DMSO:
TOM-20 (mitochondria, magenta): 0–4
(30 × 30 lm). 0–8 (10 × 10 lm).
WGA-488 (membrane, green): 0–10 (30 × 30 lm).
48 h EpiLCs + dm-aKG:
TOM-20 (mitochondria, magenta): 0–5 (30 × 30 lm). 0–9
(10 × 10 lm).
WGA-488 (membrane, green): 2–48 (30 × 30 lm).
Bright-field and epifluorescence images of cells were acquired on
an inverted Olympus microscope with Leica Application Suite soft-
ware (v4.1) and processed using Fiji software. Fluorescent image
intensity scales (in units of counts) were adjusted equally.
Western blot analysis
Cells were harvested, re-suspended in 50 mM Tris–HCl (pH 8.0)
supplemented with 1% SDS, 10 mM EDTA, 1× protease inhibitor
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cocktail (Roche) and lysed by 10 min of incubation on ice. Cell
lysates were cleared through 15 min of centrifugation at 13,000 g,
protein concentrations (determined using the Bicinchoninic Acid
Kit, Sigma-Aldrich) were adjusted, and samples were incubated for
5 min at 95°C following addition of Laemmli buffer. Proteins were
separated on 12% polyacrylamide gels using the Mini-PROTEAN
system (Bio-Rad) and transferred to an Immobilon-P transfer
membrane (Millipore). Following 2 h of blocking in 5% skimmed
milk, the membranes were incubated with primary antibodies,
diluted in 5% BSA, 0.01% TBST overnight at 4°C. Primary antibod-
ies used in this study were as follows: rabbit anti-H3K27me3 (Cell
Signaling Technology, C36B11; 1:5,000), mouse anti-H3K9me2
(Abcam, ab1220; 1:5,000), rabbit anti-H3 (Abcam, ab1791;
1:10,000), goat anti-DNMT3b (Santa Cruz Biotechnology, sc-10235;
1:1,000) and rabbit anti-IDH2 [Abcam, ab129180 (EPR7576);
1:1,000].
Histone antibody binding was visualized using IRDye 680RD,
goat anti-mouse IgG IRDye 680RD, goat anti-rabbit IgG IRDye
800CW and goat anti-mouse IgG IRDye 800CW, respectively,
secondary antibodies (LI-COR; 1:2,000 in 5% skimmed milk, 0.01%
TBST) and the LI-COR Odyssey CLx system. DNMT3b and IDH2,
respectively, antibody binding was detected by horseradish peroxi-
dase-conjugated anti-goat IgG (Dako; 1: 2,000 in 5% skimmed milk,
0.01% TBST) and anti-rabbit IgG (Dako; 1: 5,000 in 5% skimmed
milk, 0.01% TBST), respectively, in conjunction with the Western
Detection System (GE Healthcare).
ChIP-qPCR analysis
Native ChIP (nChIP) was performed as previously described (Brin-
d’Amour et al, 2015). Briefly, cells were washed, dissociated and
stored in nuclear storage buffer (Nuclei Isolation Kit; Sigma-Aldrich)
at 80°C prior to lysis in digestion buffer [1× MNase buffer (NEB);
2.5 mM DTT, 6.25% PEG-6000, 2.5 U MNase (NEB)]. Following
chromatin pre-clearance through protein A/G Dynabeads (Thermo
Fisher Scientific), the antibody–bead complex was formed by 2-h
incubation with antibody in IP buffer (20 mM Tris–HCl pH 8.0;
2 mM EDTA; 150 mM NaCl; 0.1% Triton X-100), with protein inhi-
bitor cocktail (Roche) at 4°C. Chromatin and antibody-bead complex
were then inculcated overnight at 4°C and washed, and purified
DNA was quantified by qPCR on a QuantStudio 6 Flex Real-Time
PCR System (Applied Biosystems). Antibodies used for nChIP exper-
iments were as follows: anti-H3K27me3 (Cell Signaling Technology;
C36B11; lot 8); anti-H3K9me2 (Abcam; ab1220; lot GR212253-7);
rabbit IgG (Santa Cruz Biotechnology; sc-2027; lot H2615); mouse
IgG (Santa Cruz Biotechnology; sc-2025; lot G2314). H3K9me2 and
H3K27me3, respectively, occupancy was investigated in putative
enhancer regions of candidate genes, based on three published data-
sets (Ma et al, 2011; Buecker et al, 2014; Zylicz et al, 2015). Primer
pairs used were as follows: Esrrb enhancer, forward, 50-AGGT
TTGAATGGGACAGGAG-30, reverse, 50-GATTGCACATCAAGGACT
GG-30; Arid5b enhancer, forward, 50-GGATTCAGAGAGCAAGCACA-30,
reverse, 50-TGCTTCTGCAGGAATCTCAG-30; Tfap2c enhancer,
forward, 50-GCGCTTAGGTCGCTTGGATA-30, reverse, 50-CTCGAACA
CTTGGAGTCGGG-30; Nanog enhancer, forward, 50-TTCAGTCAGG
CTGGGCAATG-30, reverse, 50-CCTCAACTGCTGCCACACTA-30;
Prdm14 enhancer, forward, 50-AAGCAGCAGGGTGGAGATAA-30,
reverse, 50-AAATGGGCTGCTAAGTGCAT-30; Pdgfa enhancer,
forward, 50-CCTCATCTTCCTCCTTCCAC-30, reverse, 50-AAATCAGAC
AGGCAGGGTGT-30; Tfap2c promoter, forward, 50-CAGCCAGATA
CAGCTTCGGG-30, reverse, 50-GATTCCGAGAAGGAGTCCGC-30.
OSN binding site analysis
For transcription factor occupancy analysis, binding of OCT4, SOX2
and NANOG (OSN) within a region of 20 kb upstream to 4 kb
downstream of the transcriptional start sites of genes of interest was
investigated, based on ChIP-seq summary data from three separate
publications (Chen et al, 2008; Marson et al, 2008; Whyte et al,
2013). A gene was defined as occupied by OSN if all three factors
bound the region in the summary data from at least two of the three
publications.
Quantification and statistical analysis
Microsoft Excel was used for statistical evaluation of gene expres-
sion (qRT–PCR), flow cytometer analysis and colony formation
assays. Data were analysed using unpaired (heteroscedastic) 1-tailed
Student’s t-tests. For comparing fold changes in gene expression
levels, statistical analysis was performed on log10-transformed data.
Statistical details of the experiments, such as the number of inde-
pendent biological replicates, definition of centre, dispersion and
significance are reported in the figure legends. Data are represented
as mean  1 SEM. Significance levels are denoted as follows:
*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005. P-values for all statistically
evaluated experiments are listed in Appendix Table S3.
Data availability
The single-cell RNA-seq data reported here have been deposited in
GEO under accession number GSE107761.
Expanded View for this article is available online.
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